Consensus is for FY25 revenue $2.64B. Narrows adjusted EBITDA view to $175M-$195M from $170M-$200M.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE:
- Fortrea reports Q3 adjusted EPS 12c, consensus 16c
- Fortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection
- Fortrea’s Phase 1 Study on D3S-001: Evaluating Food’s Impact on Drug Absorption
- Fortrea’s Phase 3 Study on AP301: A Potential Game-Changer for Hyperphosphatemia Treatment
- Fortrea’s Givinostat Study: A New Hope for Young DMD Patients